is tirzepatide still on the shortage list Lilly CEO says weight-loss drug shortage to end 'very soon', Bloomberg News reports

Compounding pharmacies can resume making tirzepatide as FDA reconsiders shortage

27.64

★★★★☆4.8 (126)

FDA Allows Compounded Tirzepatide During Shortage Review

20.95

★★★★★4.9 (98)

The FDA says it's standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli Lilly's diabetes and weight loss drugs Mounjaro and Zepbound — is over

27.01

★★★★★5.0 (157)

Eli Lilly's Weight-Loss, Diabetes Drug Shortages Are Over, FDA Says

26.91

★★★★★4.7 (84)

Tirzepatide Shortage Resolved: What It Means for Your Weight Loss Journey

21.49

★★★★★4.9 (203)

FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies are required to cease production of compounded versions of tirzepatide within the

26.02

★★★★★5.0 (176)

The Outsourcing Facilities Association (OFA) is suing the FDA after the agency removed tirzepatide (Zepbound, Mounjaro) from the federal drug shortage list without proper notice. The lawsuit claims that the FDA failed

27.70

★★★★★4.8 (132)